If you’re a small defense technology company right now, chances are you’re running on caffeine, adrenaline, and a calendar full of proposal deadlines. The U.S. military and its warfare research centers are releasing RFPs at a dizzying pace. Companies with the agility to mobilize seasoned capture teams can ratchet up their chances for wins.
As
Congratulations, your medical device is a success! But don’t celebrate yet—patent litigation may be next (objectively speaking). Patents are a strategic asset in medtech, where proprietary innovation is key to improving patient outcomes, driving company growth, and securing investment. Since competitors, investors, and opportunistic non-practicing entities (NPE) are aware of the strategic advantages of patents
Medical device manufacturers face mounting pressure to deliver innovative products while reducing costs and improving margins. To meet these challenges, many original equipment manufacturers (OEMs) outsource critical operations such as manufacturing, packaging, and distribution. This shift allows OEMs to streamline resources, eliminate factories and equipment, and focus on innovation, while contract manufacturing organizations (CMOs) step
After several years of volatility and unfavorable market dynamics, the initial public offering (IPO) market for medical technology companies is beginning to reopen meaningfully. Following the most recent IPO boom in 2020 and 2021, higher interest rates and inflation brought new IPO issuances to a near standstill from 2022 to 2024. During that period, many
The healthtech industry is experiencing intense competition as companies race to develop software and artificial intelligence (AI) tools for clinical decision support, medical telemetry, robotic surgery, surgical navigation, medical imaging analysis, drug discovery, clinical trial management, and countless other medical applications. This competitive landscape is driving substantial investment and rapid innovation, with established medtech providers
Following an extended suspension tied to ongoing security conditions in the region, U.S. consular operations in Israel have resumed after the prior closure of the U.S. Branch Office in Tel Aviv and the pause in consular processing.
There are reports from attorneys that nonimmigrant visa processing has begun moving forward. Consular
In the life sciences sector, long-term success is dependent on more than innovation alone. To secure funding, enter strategic alliances, and achieve leadership in competitive markets, companies must protect their innovations by implementing a strategic intellectual property (IP) strategy.
Patents should be the cornerstone of any life science innovator’s business strategy. Across biotechnology, pharmaceuticals, medical
With artificial intelligence tools becoming part of everyday decision-making, for some, chatbots are a first stop for help with answering questions, including questions that feel “legal” in nature. Such questions might include whether a contract clause is enforceable, how to respond to a demand letter, or what to say in an internal investigation. The AI
As innovations continue to accelerate, the technology landscape in 2026 may reach a turning point, marking a shift from research and development (R&D) to adaptation. This year’s outlook highlights a shift towards smarter, autonomous systems that operate within the physical world. Organizations that embrace this shift may thrive, while those that lag behind may risk
The U.S. Securities and Exchange Commission staff issued a joint statement on Jan. 28, 2026, providing greater clarity on the application of the federal securities laws to the category of crypto assets commonly referred to as tokenized securities. The staff introduced the statement as guidance on the taxonomies of tokenized securities to assist market participants